greeksoup/ stock research
Stock research / United States / Funds / General Catalyst Group Management, LLC

General Catalyst Group Management, LLC

CIK 1637946 · latest 13F filed 17 August 2026 · Read the filing on EDGAR

General Catalyst Group Management, LLC reported 14 US-listed holdings worth $188.5 million in its 13F for the quarter ended 30 June 2026, filed 17 August 2026. Its largest: Arrivent Biopharma Inc. (27.5%), Parabilis Medicines Inc. Com (23.2%) and Maplebear Inc. (17.9%). Against the quarter before, it opened 4 positions, added to 3, trimmed 0 and sold out of 2.

Reported holdings$188.5M+2.7% on Q1 2026
Positions14+2 on Q1 2026
The largest ten99.0%of its reported holdings
Latest 13FQ2 2026filed 17 August 2026
Where the money is
OpenedAdded toHeld
AVBP27.5%PBLS23.2%CART17.9%MAZE16.4%ODTX8.0%EIKN2.1%GUTS2.1%LIFE0.7%META

The 14 largest of its 14 positions, each sized by its share of the reported holdings, coloured by the change in shares against Q1 2026.

Reported holdings, quarter by quarter
Q3 2024: $1.43 billion in 11 positions$1.43BQ3 24Q4 2024: $1.14 billion in 11 positions$1.14BQ4 24Q1 2025: $887.5 million in 11 positions$888MQ1 25Q2 2025: $4.30 billion in 10 positions$4.30BQ2 25Q3 2025: $3.04 billion in 8 positions$3.04BQ3 25Q4 2025: $221.7 million in 7 positions$222MQ4 25Q1 2026: $183.6 million in 12 positions$184MQ1 26Q2 2026: $188.5 million in 14 positions$189MQ2 26

What the fund reported holding at each quarter's end; hover a bar for the number of positions

What its reported holdings returned

Held through each quarter, the holdings it reported returned -55.1% over the 7 quarters to 30 June 2026, against +30.2% for the S&P 500.

Its reported holdingsThe S&P 500
306090120Q3 24Q4 24Q1 25Q2 25Q3 25Q4 25Q1 26Q2 26Its holdings -55.1%S&P 500 +30.2%

Not the fund's own return: each 13F's holdings are kept unchanged until the next one, so trades inside a quarter, dividends, cash and fees are left out. A rough guide to how its picks have done over time.

What it did on the quarter

Opened 4Added 3Held 7Sold out 2
Opened: 4Added: 3Held: 7Sold out: 2

Its positions against its 13F for the quarter to 31 March 2026; a change under 0.1% of a position counts as held

Opened 4

  1. Parabilis Medicines Inc. Com PBLS$43.8 million
  2. Odyssey Therapeutics, Inc. ODTX$15.2 million
  3. DoorDash, Inc. DASH$525,911
  4. Carvana Co. CVNA$425,526

Added to 3

  1. Meta Platforms, Inc. META+662 shares · +101%
  2. Coupang Inc. Class A CPNG+18,000 shares · +49%
  3. Amazon.com Inc. AMZN+1,300 shares · +50%

Sold out of 2

  1. Samsara Inc. IOT$63.4 million last quarter
  2. Gitlab Inc. GTLB$19.9 million last quarter

What it holds

CompanySharesValueOf its bookChange in shares
Arrivent Biopharma Inc. AVBP1.5M$51.9 million27.55%no change
Parabilis Medicines Inc. Com PBLS1.6M$43.8 million23.24%new
Maplebear Inc. CART710.7K$33.7 million17.85%no change
Maze Therapeatics MAZE1.0M$30.9 million16.40%no change
Odyssey Therapeutics, Inc. ODTX810.3K$15.2 million8.04%new
Eikon Therapeutics Inc. EIKN305.2K$4.0 million2.11%no change
Fractyl Health Inc. GUTS4.9M$3.9 million2.06%-7
Ethos Technologies Inc. LIFE74.2K$1.3 million0.71%no change
Coupang Inc. Class A CPNG54.7K$949,7390.50%+18.0K
Amazon.com Inc. AMZN3.9K$925,2360.49%+1.3K
Meta Platforms, Inc. META1.3K$743,5430.39%+662
DoorDash, Inc. DASH2.9K$525,9110.28%new
Carvana Co. CVNA6.5K$425,5260.23%new
Figma Inc. FIG14.8K$268,5460.14%no change
Every US-listed position in the fund's 13F for the quarter ended 30 June 2026, by the value it reported.
Read moreChange is shares against its 13F for the quarter before; the 2 it sold out of are in the box above.